Abstract
INTRODUCTION
Hepatitis C virus (HCV) remains the most common cause of chronic liver disease and cirrhosis worldwide and is one of the leading causes of chronic hepatitis and cirrhosis in the United States with a steadily increasing prevalence over the past two decades [1, 2] . While commonly asso ciated with hepatocellular carcinoma [2] , hepatitis C infection is associated with extrahepatic malignancies including cholangiocarcinoma, nonHodgkin's lymphoma and possibly myeloma [35] . The oncogenic properties of hepatitis C are hypothesized to be secondary to chronic antigenic stimulation of the immune system, promotion of a chronic inflammatory state or direct oxidative stress [6] . Besides, chronic HCV infection has also been linked to a myriad of extrahepatic diseases including increasing the risk of renal disease and increasing the prevalence of chronic kidney disease up to 40% higher compared to noninfected patients [7, 8] .
Renal cell carcinoma (RCC), arising from the renal cortex is responsible for 80% of all renal malignancies and accounts for approximately 14000 deaths each year in the United States [9] . The risk factors for RCC such as acquired cystic kidney disease, smoking, kidney stones, obesity, hereditary factors have been described [1014] . The epidemiological studies have demonstrated an increasing incidence of RCC, particularly in African Americans [15] . Secondary to the oncogenic nature of Hepatitis C, several studies have linked chronic infection with an increased risk for development of RCC [1622] . However, the findings from these studies were contradictory. Thus, we performed this metaanalysis to examine the risk of RCC in HCVinfected patients.
MATERIALS AND METHODS

Literature search
Two investigators (Karn Wijarnpreecha and Wisit Cheungpasitporn) independently reviewed published studies indexed in MEDLINE, EMBASE, and the Coch rane database from their inception to February 2016 using the search strategy that included the terms for "hepatitis" and "renal cancer" as described in Item S1 in online supplementary data. No limitation on language was applied. A manual search for additional studies using references of selected retrieved articles was also performed. Three investigators (Karn Wijarnpreecha, Charat Thongprayoon and Wisit Cheungpasitporn) independently reviewed the titles and abstracts of the studies identified in the search based on inclusion and exclusion criteria. The full text of the included studies from the first phase was reviewed independently to ascertain whether or not they matched the inclusion criteria. We also performed a manual search of con ference proceedings from major gastroenterology and hepatology meetings for additional abstracts on the topic. When additional information was needed, we contacted the corresponding investigators of eligible studies.
Study selection
The inclusion criteria were as follows: (1) observational studies assessing the association between hepatitis C and RCC; (2) odds ratios, relative risks or hazard ratios with 95%CI were provided; and (3) individuals without HCV infection were used as comparators in cohort studies while individuals without RCC were applied as comparators in the crosssectional and casecontrol studies.
Study acceptability was individually defined by the three investigators mentioned above. Disagreements in the ascertainment of study eligibility were settled by joint agreement. Also, the quality of each study was individually appraised by each investigator. We used the validated NewcastleOttawa quality assessment scale for cohort and casecontrol studies [23] and modified NewcastleOttawa scale [24] for the crosssectional study.
Data extraction
A data collection report was utilized to derive the information from each study including name of title and the first author, year of study and publication, country, demographic data of the participants, number of partici pants, method used to diagnose the HCV infection and RCC, effect estimates (odds ratios, relative risks or hazard ratios) with 95%CI, and factors adjusted in the multivariate analysis. To assure the certainty, this data extraction process was reviewed by all investigators.
Statistical analysis
Review Manager (RevMan) 5.3 software from the Cochrane Collaboration was utilized for metaanalysis. Generic inverse variance (DerSimonian and Laird) method [25] was employed to combined adjusted point estimates and standard errors from each study. We used a randomeffect model due to the high likelihood of betweenstudy variance from different study designs and populations. Cochran's Q test and I 2 statistic were used to determine the betweenstudy heterogeneity. A value of I 2 of 0%25%, 25%50%, 50%75%, and greater than 75% embodied insignificant, low, moder ate and high heterogeneity, respectively [26] .
RESULTS
Of 5778 potentially relevant articles, 5582 articles were excluded by the title and abstract not fulfilling inclusion criteria due to the type of article, study design, population, or outcome of interest. Additionally, 189 articles were excluded (35 articles were not observational studies, and 154 articles did not describe the outcomes of interest, Macleod et al [27] 's study did not contain data on specific viral hepatitis{Macleod, 2013 #83}). Finally, seven observational studies (4 cohort and 3 case controlled studies) with 196826 patients were included in the metaanalysis [1622] . Item S2 describes the study selection flow. The characteristics and quality appraisal of the included studies of HCV and RCC are shown in Table 1 . Four studies were conducted in Europe, 2 in the United States, and 1 in Australia.
The risk of renal cell carcinoma in patients with hepatitis C virus infection
Among individuals with HCV infection, there was a significantly increased risk of RCC with the pooled risk ratio (RR) of 1.86 (95%CI: 1.113.11, I
2 =77%), as demonstrated in Figure 1 . The statistical heterogeneity was high with an I 2 of 77%. The association between RCC and HCV was marginally insignificant after the sensitivity analysis including only studies with confounder adjustment [16, 1820, 22] with a pooled RR of 1.50
(95%CI: 0.932.42, I 2 =64%), as shown in Figure 2 .
Evaluation for publication bias
Two authors (Karn Wijarnpreecha and Wisit Cheungpa sitporn) independently performed the assessment of the risk of bias of the included studies. Only minor disagreements between 2 reviewers were present and were resolved by discussion and consensus. A funnel plot was constructed to assess publication bias for the risk of RCC in HCVinfected patients ( Figure S1 ). The Figure 1 Forest plot of all included studies of the association between hepatitis C infection and renal cell carcinoma. Square data markers represent risk ratios (RRs); horizontal lines, the 95%CI with marker size reflecting the statistical weight of the study using random-effects meta-analysis. A diamond data marker represents the overall RR and 95%CI for the outcome of interest.
Figure 2 Forrest plot of all included studies in sensitivity analysis of the association between hepatitis C infection and renal cell carcinoma.
Square data markers represent risk ratios (RRs); horizontal lines, the 95%CIs with marker size reflecting the statistical weight of the study using random-effects meta-analysis. A diamond data marker represents the overall RR and 95%CI for the outcome of interest. Gordon et al [19] United States Budakoğlu et al [17] Turkey Hofmann et al [20] Sweden Gonzalez et al [18] United States funnel plot was suggestive of a small publication bias toward studies with a positive correlation between HCV infection and RCC.
DISCUSSION
This metaanalysis was conducted to summarize all presently available data on the association between HCV infection and RCC. Our study demonstrated a 1.86fold increased risk of RCC among participants who had HCV infection compared to those without HCV infection. Our analysis also illustrates that that RCC patients with HCV were significantly younger than RCC patients without HCV. The results of our study reinforce the hypothesis that HCV may accelerate the risk of developing RCC. Although the nature in which HCV induces RCC is not entirely understood, several hypotheses exist. A recent bioinformatics study demonstrated a plausible biological relationship between HCV infection and the development of RCC via the NYREN54 protein. The NYREN54 protein which is an altered ubiquitinrelated protein that plays a role in the disturbance impairs the autophagic response via to the ubiquitinprotein ligaserelated selfregulatory mechanism, which in turn promotes oncogenesis [28] . Additionally, inhibition of cytotoxic Tlymphocytedependent apoptosis by the hepatitis virus secondarily leads to a disturbance in host immunity and normal tissue homeostasis leading to carcinoma formation [29] . Lukkonen et al [30] demonstrated an increased expression of serine protease inhibitor Kazal (SPIK), a cellular protein that inhibits serine protease related apoptosis, in RCC tissue samples as an additional mechanism for HCVinduced RCC. There are several limitations in our study. Firstly, there was a high amount of statistical heterogeneity present in the completed analysis. The potential source of this heterogeneity includes variation in confounder adjusted methods (e.g., age, sex, ethnicity, and chronic kidney disease), exposure measurement, outcome ascertainments, and followup duration. Secondly, it should be noted that there was a potential small publi cation bias with a positive association between HCV infection and RCC. The possibility of selection bias could play a role in chartreviewed population base study. Finally, this metaanalysis of observational studies could only show an association. It cannot establish causality as an unknown number of confounders could play a role in the association between HCV and RCC.
In summary, this study demonstrates a potential association between HCV infection and RCC. In the new era of treatment of HCV infection, directacting antiviral agents have been demonstrated to be effective therapy and increasingly used [31] . These agents may potentially decrease the incidence of RCC in HCV patients in the long term.
COMMENTS
Background
Hepatitis C virus (HCV) is one of the leading causes of cirrhosis as the prevalence of HCV has been steadily increasing over the past two decades in the United States. Extrahepatic manifestations of HCV are common. Interestingly, HCV infection could also increase the risk of renal cell carcinoma (RCC) as observed in several epidemiologic studies.
Research frontiers
The results of those epidemiologic studies were inconsistent. To further investigate this possible association of HCV and RCC, the authors conducted this systematic review and meta-analysis of observational studies reporting the risk of RCC among HCV-infected patients.
